Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Consistent epidemiological evidence exists linking low vitamin D levels to increased risk and severity of respiratory tract infections.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Scoping review.
Scoping review
Maps the extent and characteristics of research on a topic.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
Scoping review · Frontiers in Physiology · 2020
Original publication title
Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
Copyright © 2020 Santaolalla, Beckmann, Kibaru, Josephs, Van Hemelrijck and Irshad.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To assess the association between vitamin D deficiency and increased morbidity/mortality with COVID-19 respiratory dysfunction.
Source: ObjectivesAbstract: Design
Scoping review.
Source: DesignAbstract: Data Sources
Ovid MEDLINE (1946 to 24 of April 2020) and PubMed (2020 to 17 of September 2020).
Source: Data SourcesAbstract: Eligibility Criteria for Selecting Studies
A search using the search terms: [(cholecalciferol or ergocalciferol or vitamin D2 or vitamin D3 or vitamin D or 25OHD) and (SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV or respiratory infection or acute respiratory distress syndrome or ARDS)]m.p. was conducted on the 24/04/2020 (Search A) and 17/09/2020 (Search B).
Source: Eligibility Criteria for Selecting StudiesAbstract: Results
91 studies were identified as being concerned with Acute Respiratory Infection (ARI)/Acute Respiratory Distress Syndrome (ARDS) and vitamin D, and 25 publications specifically explored the role of vitamin D deficiency in the development and progression of SARS-CoV-2/COVID-19 related ARDS. Search “A” identified three main themes of indirect evidence supporting such an association. Consistent epidemiological evidence exists linking low vitamin D levels to increased risk and severity of respiratory tract infections. We also report on plausible biological processes supporting such an association; and present weaker evidence supporting the benefit of vitamin D supplementation in reducing the risk and severity of ARIs.
Uncertainty remains about what constitutes an appropriate dosing regimen in relation to reducing risk/severity of ARI/ARDS. More recent evidence (Search B) provided new insights into some direct links between vitamin D and COVID-19; with a number of cohort and ecological studies supporting an association with PCR-positivity for SARS-CoV-2 and vitamin D deficiency. The exact efficacy of the vitamin D supplementation for prevention of, or as an adjunct treatment for COVID-19 remains to be determined; but a number of randomized control trials (RCTs) currently underway are actively investigating these potential benefits.
Source: ResultsAbstract: Conclusion
Our rapid review of literature supports the need for observational studies with COVID-19 infected populations to measure and assess vitamin D levels in relation to risk/severity and outcomes; alongside RCTs designed to evaluate the efficacy of supplementation both in preventive and therapeutic contexts. The overlap in the vitamin D associated biological pathways with the dysregulation reported to drive COVID-19 outcomes warrants further investigation.
Source: ConclusionAuthors’ abstract
Objectives
To assess the association between vitamin D deficiency and increased morbidity/mortality with COVID-19 respiratory dysfunction.
Design
Scoping review.
Data Sources
Ovid MEDLINE (1946 to 24 of April 2020) and PubMed (2020 to 17 of September 2020).
Eligibility Criteria for Selecting Studies
A search using the search terms: [(cholecalciferol or ergocalciferol or vitamin D2 or vitamin D3 or vitamin D or 25OHD) and (SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV or respiratory infection or acute respiratory distress syndrome or ARDS)]m.p. was conducted on the 24/04/2020 (Search A) and 17/09/2020 (Search B).
Results
91 studies were identified as being concerned with Acute Respiratory Infection (ARI)/Acute Respiratory Distress Syndrome (ARDS) and vitamin D, and 25 publications specifically explored the role of vitamin D deficiency in the development and progression of SARS-CoV-2/COVID-19 related ARDS. Search “A” identified three main themes of indirect evidence supporting such an association. Consistent epidemiological evidence exists linking low vitamin D levels to increased risk and severity of respiratory tract infections. We also report on plausible biological processes supporting such an association; and present weaker evidence supporting the benefit of vitamin D supplementation in reducing the risk and severity of ARIs.
Uncertainty remains about what constitutes an appropriate dosing regimen in relation to reducing risk/severity of ARI/ARDS. More recent evidence (Search B) provided new insights into some direct links between vitamin D and COVID-19; with a number of cohort and ecological studies supporting an association with PCR-positivity for SARS-CoV-2 and vitamin D deficiency. The exact efficacy of the vitamin D supplementation for prevention of, or as an adjunct treatment for COVID-19 remains to be determined; but a number of randomized control trials (RCTs) currently underway are actively investigating these potential benefits.
Conclusion
Our rapid review of literature supports the need for observational studies with COVID-19 infected populations to measure and assess vitamin D levels in relation to risk/severity and outcomes; alongside RCTs designed to evaluate the efficacy of supplementation both in preventive and therapeutic contexts. The overlap in the vitamin D associated biological pathways with the dysregulation reported to drive COVID-19 outcomes warrants further investigation.
Publication and source details
Original title: Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction: A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
Aida Santaolalla; Kerri Beckmann; Joyce Kibaru; Debra Josephs; Mieke Van Hemelrijck; Sheeba Irshad
Frontiers in Physiology · 2020
Edited by: Gaetano Santulli, Columbia University, United States
Reviewed by: William B. Grant, Sunlight, Nutrition, and Health Research Center, United States; Hari H. Subramanian, Boston Scientific, United States; Celestino Sardu, Second University of Naples, Italy
This article was submitted to Respiratory Physiology, a section of the journal Frontiers in Physiology
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T15:17:16.557161+00:00
DOI: 10.3389/fphys.2020.564387 · PMC7726316